Εθνικό & Καποδιστριακό Πανεπιστήμιο Αθηνών
Τηλέφωνο Γραμματείας: 2105831336, Email: bofthalmologiki@attikonhospital.gov.gr
Title Image

ΔΗΜΟΣΙΕΥΣΕΙΣ

  1. Lampsas S, Agapitou C, Chatzirallis A, Papavasileiou G, Poulakis D, Pegka S, Theodossiadis P, Lambadiari V, Chatziralli I. MicroRNA (miRNA) in the Pathogenesis of Diabetic Retinopathy: A Narrative Review. Genes (Basel). 2025 Sep 9;16(9):1060.
  2. Kazantzis D, Machairoudia G, Theodossiadis P, Chatziralli I. Macular Choroidal Thickness in Keratoconus: Systematic Review and Meta-Analysis of Current Evidence. Diagnostics (Basel). 2025 Sep 19;15(18):2394.
  3. Stefanou MI, Chatziralli I, Lambadiari V, Mengel A, Foska A, Chondrogianni M, Bakola E, Tsalouchidou PE, Mitsikostas DD, Siasos G, Ziemann U, Tsivgoulis G. Efficacy and Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis. Eur J Neurol. 2025 Sep;32(9):e70358.
  4. Dettoraki M, Vandorou KT, Tsoukalas D, Basagianni E, Chatziralli I, Theodossiadis P, Loukides S, Toumpanakis D. Ocular manifestations in COPD patients. An underrecognized comorbidity. Respir Med. 2025 Oct;247:108313.
  5. Rouvas A, Datseris I, Georgalas I, Tsilimbaris M, Tranos P, Theodosiadis P, Tzanidaki ME, Kardara M, Tyrlis K, Spyropoulos D, Datseri R, Stavrakakis A, Tranou M, Kazantzidou P, Gouliopoulos N. Impact of the COVID-19 pandemic on the incidence and recurrence of central serous chorioretinopathy in Greece: a multicenter study. Int Ophthalmol. 2025 Aug 12;45(1):329.
  6. Xydias EM, Liasidi PN, Papageorgouli D, Tsakos E, Gouliopoulos N, Thanasas I, Daponte A, Ziogas AC. Three-dimensional transvaginal ultrasound versus MRI in the diagnosis and classification of congenital uterine anomalies: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2025 Aug;312:114560.
  7. Rouvas A, Datseris I, Malvina-Efthymia T, Kardara M, Theodossiadis P, Gouliopoulos N. LONG-TERM NATURAL COURSE OF AVASCULAR SEROUS PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION. Retina. 2025 Oct 1;45(10):1854-1861.
  8. Lampsas S, Lambadiari V, Agapitou C, Lampsa A, Oikonomou E, Siasos G, Chatziralli I. Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2025 Jun 24;61(7):1137.
  9. Smarlamaki R, Koutsoumpi EA, Psaltopoulou T, Kalarakis G, Theodossiadis P, Georgalas I, Peponis V, Chatziralli I, Sergentanis TN. Risk Factors and Cumulative Incidence of Cystoid Macular Edema After Simple Cataract Surgery: A Systematic Review and Meta-Analysis. Cureus. 2025 May 16;17(5):e84212.
  10. Gkiala A, Agapitou C, Dimitriou E, Haidich AB, Tziola T, Theodossiadis P, Mataftsi A, Chatziralli I. Intravitreal Dexamethasone Implant for Patients With Central Retinal Vein Occlusion: Four-Year Outcomes in a Real-World Study. Cureus. 2025 Mar 11;17(3):e80391.
  11. Gouliopoulos N, Bouratzis N, Kympouropoulos S, Datseris I, Georgalas I, Theodossiadis P, Rouvas A. Mental Health Consequences of Age-Related Macular Degeneration: Exploring Depression Prevalence and Severity in Wet and Dry Forms. Clin Gerontol. 2025 May 15:1-9.
  12. Rouvas A, Georgalas I, Tzanidaki ME, Gouliopoulos N. Spontaneous resolution of photodynamic therapy-induced acute exudative maculopathy in a patient suffering from polypoidal choroidal vasculopathy: A case report with 3-year follow-up. Oman J Ophthalmol. 2025 Feb 25;18(1):61-65.
  13. Chatziralli I, Theofilou P, Kazantzis D, Agapitou C, Karmiris E, Risi-Koziona A, Theodossiadis G, Georgalas I, Theodossiadis P. Intravitreal aflibercept for macular edema due to central retinal vein occlusion: 5-year results of a real-world study (INTRAMED-CRVO). Retina. 2025 Apr 2.
  14. Mavridou EP, Sergentanis TN, Kapetanios I, Theodossiadis P, Chatziralli I. Intravitreal Anti-Vascular Endothelial Growth Factor Agents in Patients with Neovascular Age-Related Macular Degeneration and Retinal Pigment Epithelial Tear: A Systematic Review and Meta-Analysis. Semin Ophthalmol. 2025 Apr 1:1-10.
  15. Agapitou C, Sergentanis TN, Papageorgiou EG, Theodossiadis P, Ikonomidis I, Lambadiari V, Chatziralli I. Investigation of the Potential Association Between Atherosclerotic Cardiovascular Disease Risk Score and Diabetic Retinopathy in Patients with Type 2 Diabetes: A Cross-Sectional Study. Biomedicines. 2025 Mar 5;13(3):633.
  16. Kazantzis D, Papathanasiou K, Machairoudia G, Theodossiadis P, Chatziralli I. Assessment of arterial stiffness in patients with diabetic retinopathy: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2025 May;223:112123.
  17. Kazantzis D, Machairoudia G, Theodossiadis P, Chatziralli I. The Neutrophil to Lymphocyte Ratio and Other Full Blood Count Indices in Retinal Diseases: A Systematic Review of the Literature. Medicina (Kaunas). 2025 Jan 14;61(1):125.
  18. Datseris I, Rouvas A, Tzanidaki ME, Kardara M, Geros V, Gouliopoulos N. Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis. Clin Ophthalmol. 2025 Jan 21;19:217-225.
  19. Gouliopoulos N, Roumeliotis I, Oikonomou D, Kympouropoulos S, Arkoudis NA, Rouvas A, Georgalas I, Theodossiadis P. Photopsias are associated with greater levels of depression and anxiety. Clin Exp Optom. 2025 Jan 13:1-5.
  20. Rouvas A, Theodossiadis P, Georgalas I, Gouliopoulos N. Complete resolution of subretinal fluid of the fellow eye after aflibercept injection in wet age-related macular degeneration. Retin Cases Brief Rep. 2025 Jan 1;19(1):125-128.
  21. Korakas E, Pavlidis G, Lampsas S, Agapitou C, Risi-Koziona A, Kountouri A, Pliouta L, Katogiannis K, Pililis S, Thymis J, Oikonomou E, Siasos G, Ikonomidis I, Lambadiari V, Chatziralli I. Endothelial Glycocalyx Damage and Arterial Thickness in Patients with Retinal Vein Occlusion (RVO). J Clin Med. 2024 Dec 28;14(1):111.
  22. Pappelis K, Risi-Koziona A, Agapitou C, Korakas E, Thymis J, Pavlidis G, Lampsas S, Kountouri A, Pliouta L, Georgalas I, Theodossiadis P, Lambadiari V, Ikonomidis I, Chatziralli I. Retinal Microvascular Changes in Association with Endothelial Glycocalyx Damage and Arterial Stiffness in Patients with Retinal Vein Occlusion: A Cross-Sectional Study. Biomedicines. 2024 Nov 9;12(11):2564.
  23. Agapitou C, Sergentanis TN, Thymis J, Pavlidis G, Lampsas S, Korakas E, Kountouri A, Pliouta L, Karmiris E, Lagiou A, Theodossiadis P, Lambadiari V, Ikonomidis I, Chatziralli I. Retinal Microvascular Changes in Association with Endothelial Glycocalyx Damage and Arterial Stiffness in Patients with Diabetes Mellitus Type 2: A Cross-Sectional Study in a Greek Population. J Pers Med. 2024 Sep 19;14(9):995.
  24. Chatziralli I, Agapitou C, Dimitriou E, Kapsis P, Kazantzis D, Risi-Koziona A, Theodossiadis G, Theodossiadis P. Vitreoretinal Interface Abnormalities in Patients With Retinal Vein Occlusion in a Tertiary Referral Center. Cureus. 2024 Aug 11;16(8):e66638.
  25. Georgiadis O, Pappelis K, McHugh JA, Moraitis A, Theodossiadis PG, Grabowska A. No optic pit serous maculopathy associated with an intraorbital optic nerve sheath lesion. Can J Ophthalmol. 2024 Aug;59(4):e393-e395.
  26. Pantelidou M, Dimitriou E, Gkontopoulos K, Thomopoulos T, Pappa V, Papageorgiou SG, Theodossiadis P, Chatziralli I. Optic Disc Infiltration as a Sign of Multiple Myeloma Recurrence. J Hematol. 2024 Aug;13(4):164-167.
  27. Machairoudia G, Kazantzis D, Chatziralli I, Theodossiadis G, Georgalas I, Theodossiadis P. Microvascular changes after pars plana vitrectomy for rhegmatogenous retinal detachment repair: A comparative study based on gas tamponade agent. Eur J Ophthalmol. 2024 Jul;34(4):1247-1254.
  28. Kazantzis D, Machairoudia G, Theodossiadis P, Chatziralli I. Subfoveal choroidal thickness changes in patients with pseudoexfoliation syndrome (PEX) compared to healthy controls: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2024 Jun;47:104095.
  29. Gouliopoulos N, Siasos G, Oikonomou E, Sapounas S, Rouvas A, Ziogas AC, Moschos MM, Tousoulis D. The Association of Systemic Endothelial Dysfunction With Diffuse Diabetic Macular Edema. Angiology. 2024 Jun 18:33197241263384.
  30. Kazantzis D, Machairoudia G, Kandarakis S, Theodossiadis G, Theodossiadis P, Chatziralli I. Retinal Nerve Fiber Layer Changes in Patients With Chronic Obstructive Pulmonary Disease Compared to Healthy Controls: A Meta-analysis. Ophthalmic Surg Lasers Imaging Retina. 2024 Jun;55(6):334-342.
  31. Machairoudia G, Kazantzis D, Chatziralli I, Kampoli K, Ntavatzikos A, Theodossiadis P, Koumarianou A. Prevalence and risk factors of dry eye disease in patients treated with aromatase inhibitors for breast cancer. Clin Exp Optom. 2024 May;107(4):415-419.
  32. Ragkousis A, Kazantzis D, Georgalas I, Theodossiadis P, Kroupis C, Chatziralli I. PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study. Genes (Basel). 2024 May 30;15(6):712.
  33. Gouliopoulos N, Oikonomou D, Karygianni F, Rouvas A, Kympouropoulos S, Moschos MM. The association of symptomatic vitreous floaters with depression and anxiety. Int Ophthalmol. 2024 May 7;44(1):218.
  34. Ragkousis A, Kazantzis D, Georgalas I, Theodossiadis P, Kroupis C, Chatziralli I. Association of PON1, APOE and SDF-1 Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion. Semin Ophthalmol. 2024 Apr;39(3):201-208.
  35. Pappelis K, Chatziralli I, Georgiadis O, Theodossiadis GP, Theodossiadis PG, Jansonius NM. The retinal ganglion cells in metabolic syndrome. Ann Transl Med. 2024 Feb 1;12(1):2.
  36. Pappelis K, Chatziralli I, Georgiadis O, Theodossiadis GP, Theodossiadis PG, Jansonius NM. The retinal ganglion cells in metabolic syndrome. Ann Transl Med. 2024 Feb 1;12(1):2.
  37. Chatziralli I, Agapitou C, Dimitriou E, Kapsis P, Kazantzis D, Machairoudia G, Georgiadis O, Theodossiadis G, Theodossiadis P. Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study. Semin Ophthalmol. 2024 Jan;39(1):96-101.
  38. Blazaki S, Blavakis E, Chlouverakis G, Bontzos G, Chatziralli I, Smoustopoulos G, Dimitriou E, Stavrakakis A, Kabanarou S, Xirou T, Vavvas DG, Tsilimbaris MK. Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes. Graefes Arch Clin Exp Ophthalmol. 2023 Dec;261(12):3425-3436.
  39. Chatziralli I, Dimitriou E, Agapitou C, Kazantzis D, Kapsis P, Morogiannis N, Kandarakis S, Theodossiadis G, Theodossiadis P. Optical Coherence Tomography Angiography Changes in Macular Area in Patients with Proliferative Diabetic Retinopathy Treated with Panretinal Photocoagulation. Biomedicines. 2023 Nov 26;11(12):3146.
  40. Datseris I, Bouratzis N, Kotronis C, Datseris I, Tzanidaki ME, Rouvas A, Gouliopoulos N. One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration. Int J Ophthalmol. 2023 Sep 18;16(9):1496-1502.
  41. Rouvas A, Bouratzis N, Georgalas I, Gouliopoulos N. Is there any association between the frequency of wet age-related macular degeneration recurrences and the seasons of the year? Int Ophthalmol. 2023 Sep;43(9):3287-3295.
  42. Andrikopoulou A, Koutsoukos K, Chatziralli I, Theodossiadis P, Tsivgoulis G, Tzartos J, Anastasakis A, Zagouri F, Dimopoulos MA. Intravenous rituximab and oral cyclophosphamide for the treatment of cancer‑associated retinopathy in a patient with epithelial ovarian cancer: A case report. Oncol Lett. 2023 Jun 1;26(1):308.
  43. Machairoudia G, Kazantzis D, Chatziralli I, Theodossiadis G, Georgalas I, Theodossiadis P. Vision-Related Quality of Life in Patients With Rhegmatogenous Retinal Detachment Treated With Pars-Plana Vitrectomy: Impact of Gas Tamponade. Cureus. 2023 May 13;15(5):e38969.
  44. Kazantzis D, Machairoudia G, Theodossiadis G, Theodossiadis P, Chatziralli I. Retinal microvascular changes in patients recovered from COVID-19 compared to healthy controls: A meta-analysis. Photodiagnosis Photodyn Ther. 2023 Jun;42:103556.
  45. Kapsis P, Agapitou C, Dimitriou E, Theodossiadis P, Chatziralli I. Branch Retinal Vein Occlusion After COVID-19 Infection: A Case Report. Cureus. 2023 Apr 26;15(4):e38172.
  46. Kazantzis D, Sergentanis TN, Machairoudia G, Dimitriou E, Kroupis C, Theodossiadis G, Theodossiadis P, Chatziralli I. Correlation Between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Retinal Vein Occlusion. Ophthalmol Ther. 2023 Apr;12(2):1239-1249.
  47. Aissopou E, Protogerou A, Theodossiadis P, Sfikakis PP, Chatziralli I. Alterations in Retinal Vessel Diameters in Patients with Retinal Vein Occlusion before and after Treatment with Intravitreal Ranibizumab. J Pers Med. 2023 Feb 17;13(2):351.
  48. Chatziralli I, Kazantzis D, Kroupis C, Machairoudia G, Dimitriou E, Theodossiadis G, Theodossiadis P, Sergentanis TN. The impact of laboratory findings and optical coherence tomography biomarkers on response to intravitreal anti-VEGF treatment in patients with retinal vein occlusion. Int Ophthalmol. 2022 Nov;42(11):3449-3457.
  49. Bourouki E, Dimitriou E, Chatzipantelis A, Kapsis P, Theodossiadis G, Theodossiadis P, Chatziralli I. Co-existence of Age-Related Macular Degeneration and Diabetic Retinopathy in a Tertiary Referral Center in Greece. Cureus. 2022 Nov 3;14(11):e31051.
  50. Chatziralli I, Dimitriou E, Chatzirallis A, Aissopou E, Kazantzis D, Theodossiadis G, Theodossiadis P. Efficacy and safety of vitamin supplements with resveratrol in diabetic macular edema: Long-term results of a comparative study. Eur J Ophthalmol. 2022 Sep;32(5):2735-2739.
  51. Gouliopoulos N, Siasos G, Oikonomou D, Oikonomou E, Konsola T, Kollia C, Athanasiou D, Dimitropoulos S, Rouvas A, Kassi E, Tousoulis D, Moschos MM. The association of T786C and G894T polymorphisms of eNOS gene with diabetic retinopathy in Greece. Eur J Ophthalmol. 2022 Sep;32(5):2582-2588.
  52. Rouvas A, Datseris I, Androudi S, Tsilimbaris M, Kabanarou SA, Pharmakakis N, Koutsandrea C, Charonis A, Kousidou O, Pantelopoulou G. A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study. Clin Ophthalmol. 2022 Aug 12;16:2579-2593.
  53. Chatziralli I, Dimitriou E, Lambadiari V, Kazantzis D, Kapsis P, Theodossiadis G, Theodossiadis P, Sergentanis TN. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema. Semin Ophthalmol. 2022 Jul 4;37(5):668-675.
  54. Kazantzis D, Machairoudia G, Kroupis C, Theodossiadis G, Theodossiadis P, Chatziralli I. Complete Blood Count-Derived Inflammation Indices and Retinal Vein Occlusion: A Case-Control Study. Ophthalmol Ther. 2022 Jun;11(3):1241-1249.
  55. Gouliopoulos N, Siasos G, Bouratzis N, Oikonomou E, Kollia C, Konsola T, Oikonomou D, Rouvas A, Kassi E, Tousoulis D, Moschos MM. Polymorphism analysis of ADIPOQ gene in Greek patients with diabetic retinopathy. Ophthalmic Genet. 2022 Jun;43(3):326-331.
  56. Chatziralli IP, Kazantzis D, Chatzirallis AP, Machairoudia G, Papageorgiou EG, Theodossiadis GP, Psaltopoulou T, Theodossiadis PG, Sergentanis TN. Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1445-1456.
  57. Kazantzis D, Theodossiadis P, Kroupis C, Theodossiadis G, Chatziralli I. Vitamin B12 and Folate as Risk Factors for Retinal Vein Occlusion: A Meta-Analysis. Klin Monbl Augenheilkd. 2022 May;239(5):709-716.
  58. Chatziralli I, Touhami S, Cicinelli MV, Agapitou C, Dimitriou E, Theodossiadis G, Theodossiadis P. Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. Eye (Lond). 2022 Apr;36(4):692-703.
  59. Cicinelli MV, Chatziralli I, Touhami S, Smaoui A, Tombolini B, Nassisi M, Theodossiadis P, Lattanzio R, Bandello F. Epiretinal Membrane Peeling in Eyes with Retinal Vein Occlusion: Visual and Morphologic Outcomes. Ophthalmol Ther. 2022 Apr;11(2):661-675.
  60. Chatziralli I, Milionis I, Christodoulou A, Theodossiadis P, Kitsos G. The Role of Vessel Density as Measured by Optical Coherence Tomography Angiography in the Evaluation of Pseudoexfoliative Glaucoma: A Review of the Literature. Ophthalmol Ther. 2022 Apr;11(2):533-545.
  61. Bezatis A, Georgou I, Dedes J, Theodossiadis P, Chatziralli I. Nepafenac in cataract surgery. Clin Exp Optom. 2022 Apr;105(3):263-267.
  62. Chatziralli I, Theodossiadis G, Chatzirallis A, Dimitriou E, Parikakis E, Theodossiadis P. Evolution of macular microvasculature and retinal layers alterations in patients with macula off retinal detachment after vitrectomy. Eur J Ophthalmol. 2022 Jan;32(1):520-526.
  63. Stamatiou ME, Kazantzis D, Theodossiadis P, Chatziralli I. Depression in glaucoma patients: A review of the literature. Semin Ophthalmol. 2022 Jan 2;37(1):29-35.
  64. Rouvas A, Gouliopoulos N, Douvali M, Koutsocheras G, Theodorou M, Bouratzis N, Bougatsou P, Theodossiadis P. One year outcomes of treat and extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy. Eur J Ophthalmol. 2021 Nov;31(6):2868-2875.
  65. Chatzirallis A, Varaklioti A, Sergentanis TN, Theodossiadis P, Chatziralli I. Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study. Semin Ophthalmol. 2021 Nov 17;36(8):658-664.
  66. Chatziralli I, Machairoudia G, Kazantzis D, Theodossiadis G, Theodossiadis P. Inverted internal limiting membrane flap technique for myopic macular hole: A meta-analysis. Surv Ophthalmol. 2021 Sep-Oct;66(5):771-780.
  67. Dimitriou E, Sergentanis TN, Lambadiari V, Theodossiadis G, Theodossiadis P, Chatziralli I. Correlation between Imaging Morphological Findings and Laboratory Biomarkers in Patients with Diabetic Macular Edema. J Diabetes Res. 2021 Aug 13;2021:6426003.
  68. Chatziralli I. Ranibizumab for the treatment of diabetic retinopathy. Expert Opin Biol Ther. 2021 Aug;21(8):991-997.
  69. Papadopoulou MK, Chatziralli I, Tzika K, Chiras D, Kitsos G, Kroupis C. Correlation of the intronic LOXL1 polymorphism rs11638944 with pseudoexfoliation syndrome and glaucoma in a Greek population. Ophthalmic Genet. 2021 Aug;42(4):405-411.
  70. Chatziralli I, Loewenstein A. Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature. Pharmaceutics. 2021 Jul 26;13(8):1137.
  71. Chatziralli I, Theodossiadis G, Dimitriou E, Theodossiadis P. Evaluation of morphological characteristics of diabetic macular edema in patients with non-proliferative versus proliferative diabetic retinopathy: a spectral-domain optical coherence tomography study. Int Ophthalmol. 2021 Jul;41(7):2417-2424.
  72. Dimitriou E, Chatzirallis A, Katopodis S, Theodossiadis G, Theodossiadis P, Chatziralli I. Cancer-associated retinopathy 4 years after surgery for ovarian cancer. Oman J Ophthalmol. 2021 Jun 28;14(2):108-111.
  73. Chatziralli I, Dimitriou E, Kazantzis D, Machairoudia G, Theodossiadis G, Theodossiadis P. Effect of COVID-19-Associated Lockdown on Patients With Diabetic Retinopathy. Cureus. 2021 May 4;13(5):e14831.
  74. 74. Stavrakas P, Christou EE, Ananikas K, Tsiogka A, Tranos P, Theodossiadis P, Stefaniotou M, Chatziralli I. Sensitivity of spectral domain optical coherence tomography in the diagnosis of posterior vitreous detachment in vitreomacular interface disorders: A prospective cohort study. Eur J Ophthalmol. 2021 May 31:11206721211020644.
  75. Chatziralli I, Chatzirallis A, Kazantzis D, Dimitriou E, Machairoudia G, Theodossiadis G, Parikakis E, Theodossiadis P. Predictive Factors for Long-Term Postoperative Visual Outcome in Patients with Macula-Off Rhegmatogenous Retinal Detachment Treated with Vitrectomy. Ophthalmologica. 2021;244(3):213-217.
  76. Chatziralli I, Papadakou P, Dimitriou E, Kazantzis D, Kapsis P, Theodossiadis G, Papathanassiou M, Theodossiadis P. The effect of intravitreal anti-vascular endothelial growth factor injections on corneal endothelium in patients with diabetic macular oedema. Cutan Ocul Toxicol. 2021 Jun;40(2):66-69.
  77. Chatziralli I, Kazantzis D, Theodossiadis G, Theodossiadis P, Sergentanis TN. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study. Ophthalmic Res. 2021;64(2):230-236.
  78. Theodossiadis G, Theodossiadis P, Chatziralli I. The impact of scleral buckling technique application in diminishing high myopia. Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):557-558.
  79. Stavrakas P, Karmiris E, Tranos P, Ananikas K, Tooulias C, Rouvas A, Androu Α. Paracentral Acute Middle Maculopathy following Surgically Induced Branch Retinal Artery Occlusion During Vitrectomy. Case Rep Ophthalmol. 2021 Jan 7;12(1):25-31.
  80. Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular Edema after Successful Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: Factors Affecting Edema Development and Considerations for Treatment. Ocul Immunol Inflamm. 2021 Jan 2;29(1):187-192.
  81. Zisimopoulos A, Klavdianou O, Theodossiadis P, Chatziralli I. The Role of the Microbiome in Age-Related Macular Degeneration: A Review of the Literature. Ophthalmologica. 2021;244(3):173-178.
  82. Chatziralli I, Theodossiadis G, Parikakis E, Chatzirallis A, Dimitriou E, Theodossiadis P. Inner retinal layers’ alterations and microvasculature changes after vitrectomy for rhegmatogenous retinal detachment. Int Ophthalmol. 2020 Dec;40(12):3349-3356.
  83. Chatziralli I, Dimitriou E, Xirou T, Kabanarou SA, Theodossiadis G, Theodossiadis P. Optical coherence tomography biomarkers as predictive factors for postoperative visual acuity in patients with epiretinal membrane treated with vitrectomy. Oman J Ophthalmol. 2020 Nov 2;13(3):136-140.
  84. Chatziralli I, Dimitriou E, Theodossiadis G, Kazantzis D, Theodossiadis P. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study. Acta Diabetol. 2020 Oct;57(10):1219-1225.
  85. Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Association between the patterns of diabetic macular edema and photoreceptors’ response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study. Int Ophthalmol. 2020 Oct;40(10):2441-2448.
  86. Gouliopoulos N, Siasos G, Moschos MM, Oikonomou E, Rouvas A, Bletsa E, Stampouloglou P, Siasou G, Paraskevopoulos T, Vlasis K, Marinos G, Tousoulis D. Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion. Vasc Med. 2020 Aug;25(4):302-308.
  87. Papadakou P, Chatziralli I, Papathanassiou M, Lambadiari V, Siganos CS, Theodossiadis P, Kozobolis V. The Effect of Diabetes Mellitus on Corneal Endothelial Cells and Central Corneal Thickness: A Case-Control Study. Ophthalmic Res. 2020;63(6):550-554.
  88. Chatziralli I, Karamaounas A, Dimitriou E, Kazantzis D, Theodossiadis G, Kozobolis V, Theodossiadis P. Peripapillary Retinal Nerve Fiber Layer Changes in Patients with Diabetes Mellitus: A Case-control Study. Semin Ophthalmol. 2020 May 18;35(4):257-260.
  89. Theodossiadis G, Theodossiadis P, Chatziralli I. Thoughts and Challenges for the Current Treatment of Optic Disc Pit Maculopathy. Semin Ophthalmol. 2020 May 18;35(4):232-236.
  90. Chatziralli I, Dimitriou E, Theodossiadis G, Bourouki E, Bagli E, Kitsos G, Theodossiadis P. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study. Int Ophthalmol. 2020 Apr;40(4):841-847.
  91. Chatziralli I, Dimitriou E, Theodossiadis G, Kazantzis D, Alonistiotis D, Theodossiadis P. Efficacy of intravitreal dexamethasone implant for the treatment of macular oedema after pars plana vitrectomy for rhegmatogenous retinal detachment: long-term outcomes. Cutan Ocul Toxicol. 2020 Mar;39(1):25-30.
  92. Chatziralli I. The impact of LEAVO study in Greece. Eye (Lond). 2020 Feb;34(2):213-214.
  93. Chatziralli I, Theodossiadis P, Theodossiadis G. New Observations regarding the Assessment of Cilioretinal Arteries Coexistence with Optic Disc Pit. Semin Ophthalmol. 2019;34(5):375-379.
  94. Chatziralli I, Dimitriou E, Theodossiadis G, Chatzirallis A, Kazantzis D, Theodossiadis P. Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes. Ophthalmologica. 2019;242(1):16-21.
  95. Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature. Ophthalmol Ther. 2019 Jun;8(2):227-234.
  96. Chatzara A, Chronopoulou I, Theodossiadis G, Theodossiadis P, Chatziralli I. XEN Implant for Glaucoma Treatment: A Review of the Literature. Semin Ophthalmol. 2019;34(2):93-97.
  97. Rouvas A, Chatziralli I, Androu A, Mpougatsou P, Alonistiotis D, Douvali M, Kabanarou SA, Theodossiadis P. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration. Int Ophthalmol. 2019 Feb;39(2):431-440.
  98. Chatziralli I, Saitakis G, Dimitriou E, Chatzirallis A, Stoungioti S, Theodossiadis G, Theodossiadis P. Angioid streaks: A Comprehensive Review From Pathophysiology to Treatment. Retina. 2019 Jan;39(1):1-11.
  99. Gouliopoulos NS, Kalogeropoulos C, Lavaris A, Rouvas A, Asproudis I, Garmpi A, Damaskos C, Garmpis N, Kostakis A, Moschos MM. Association of serum inflammatory markers and diabetic retinopathy: a review of literature. Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7113-7128.
  100. Rouvas A, Gouliopoulos NS, Moschos MM, Theodossiadis P. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report. BMC Ophthalmol. 2018 Oct 12;18(1):267.
  101. Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris’ alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings. Int Ophthalmol. 2018 Oct;38(5):1887-1893.
  102. Theodorou-Kanakari A, Karampitianis S, Karageorgou V, Kampourelli E, Kapasakis E, Theodossiadis P, Chatziralli I. Current and Emerging Treatment Modalities for Leber’s Hereditary Optic Neuropathy: A Review of the Literature. Adv Ther. 2018 Oct;35(10):1510-1518. Doi
  103. Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. Int J Retina Vitreous. 2018 Sep 19;4:33.
  104. Chatziralli I, Theodossiadis P, Theodossiadis GP. Optic disk pit maculopathy: current management strategies. Clin Ophthalmol. 2018 Aug 10;12:1417-1422.
  105. Chatziralli I. Editorial – Suboptimal response to intravitreal anti-VEGF treatment for patients with diabetic macular edema: is there any point in switching treatment? Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):5047-5050.
  106. Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1217-1224.
  107. Chatziralli I, Theodossiadis G, Panagiotidis D, Pousoulidi P, Theodossiadis P. Choriocapillaris Vascular Density Changes in Patients with Drusen: Cross-Sectional Study Based on Optical Coherence Tomography Angiography Findings. Ophthalmol Ther. 2018 Jun;7(1):101-107.
  108. Chatziralli IP, Theodossiadis PG, Steel DHW. Internal limiting membrane peeling in macular hole surgery; why, when, and how? Retina. 2018 May;38(5):870-882.
  109. Chatziralli I, Chatzipantelis A, Dimitriou E, Mpourouki E, Theodossiadis G, Theodossiadis P. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema. Clin Exp Optom. 2018 May;101(3):397-399.
  110. Chatziralli I, Theodossiadis G, Chatzirallis A, Parikakis E, Mitropoulos P, Theodossiadis P. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data. Retina. 2018 Mar;38(3):559-568.
  111. Chatziralli IP. The Role of Glycemic Control and Variability in Diabetic Retinopathy. Diabetes Ther. 2018 Feb;9(1):431-434.
  112. Chatziralli I, Stavrakas P, Theodossiadis G, Ananikas K, Dimitriou E, Theodossiadis P. The Impact of Epiretinal Membrane in Neovascular Age-Related Macular Degeneration Treatment: A Spectral-Domain Optical Coherence Tomography Study. Semin Ophthalmol. 2018;33(5):651-656.
  113. Chatziralli I, Theodossiadis P, Parikakis E, Dimitriou E, Xirou T, Theodossiadis G, Kabanarou SΑ. Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome. Diabetes Ther. 2017 Dec;8(6):1393-1404.
  114. Chatziralli I, Theodossiadis G, Kabanarou SA, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2077-2078.
  115. Chatziralli I, Theodossiadis P, Nicholson L, Steel D. Advances in Vitreoretinal Interface Disorders. J Ophthalmol. 2017;2017:7612712.
  116. Chatziralli I, Theodossiadis G, Brouzas D, Theodossiadis P. Incidence and Evolution of Subretinal Precipitates in Optic Disc Pit Maculopathy. Eur J Ophthalmol. 2017 Nov 8;27(6):769-773.
  117. Chatziralli IP, Sergentanis TN. Ocular gene therapy for neovascular AMD: a new era? Lancet. 2017 Nov 11;390(10108):2139-2140.
  118. Chatziralli I, Theodossiadis G, Kabanarou SA, Parikakis E, Xirou T, Mitropoulos P, Theodossiadis P. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study. Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1899-1905.
  119. Chatziralli I, Theodossiadis G, Brouzas D, Emfietzoglou I, Theodossiadis P. Optical Coherence Tomography Evolution in a Case of X-Linked Juvenile Retinoschisis: 15 Years of Follow-Up. Case Rep Ophthalmol. 2017 Sep 14;8(3):459-464.
  120. Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab vs. Aflibercept for Macular Edema due to Central Retinal Vein Occlusion. Ophthalmol Retina. 2017 Jul-Aug;1(4):355-356.
  121. Chatziralli I, Theodossiadis G, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1459-1460.
  122. Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data. Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1093-1100.
  123. Chatziralli IP. The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus. Diabetes Ther. 2017 Apr;8(2):209-212.
  124. Chatziralli I, Theodossiadis G, Douvali M, Rouvas AA, Theodossiadis P. Eccentric Macular Hole after Pars Plana Vitrectomy for Idiopathic Macular Hole: A Case Report. Case Rep Ophthalmol. 2017 Feb 20;8(1):116-119.
  125. Chatziralli I, Theodossiadis G, Panagiotidis D, Emfietzoglou I, Grigoropoulos V, Theodossiadis P. Long-Term Changes of Macular Thickness after Pars Plana Vitrectomy in Optic Disc Pit Maculopathy: A Spectral-Domain Optical Coherence Tomography Study. Semin Ophthalmol. 2017;32(3):302-308.
  126. Chatziralli I, Theodossiadis G, Datseris I, Parikakis E, Theodossiadis P. Anatomical and Functional Changes in the Coexistence of Vitreomacular Traction and Epiretinal Membrane: A Spectral-Domain Optical Coherence Tomography Study. Ophthalmic Res. 2017;57(1):54-59.
  127. Chatziralli I, Theodossiadis G, Grigoropoulos V, Datseris I, Chatzirallis A, Theodossiadis P. Comparison of macular findings due to vitreomacular traction alone or in association with epiretinal membrane. Eur J Ophthalmol. 2017 Jan 19;27(1):86-92.
  128. Chatziralli IP, Theodossiadis GP, Parikakis E, Datseris I, Theodossiadis P. Complications of intravitreal ocriplasmin for vitreomacular traction and macular hole: a prospective spectral-domain optical coherence tomography study. Cutan Ocul Toxicol. 2016 Dec;35(4):263-9.
  129. Theodossiadis G, Chatziralli I, Theodossiadis P. Abnormal traction of the vitreous detected by swept-source optical coherence tomography is related to the maculopathy associated with optic disc pits. Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1857-8.
  130. Chatziralli I, Theodossiadis G, Xanthopoulou P, Miligkos M, Sivaprasad S, Theodossiadis P. Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications. Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1247-56.
  131. Theodossiadis GP, Chatziralli IP, Theodossiadis PG. Inverted Internal Limiting Membrane Insertion for Macular Hole-Associated Retinal Detachment in High Myopia. Am J Ophthalmol. 2016 May;165:206-7.
  132. Rouvas A, Chatziralli I, Androu A, Papakonstantinou S, Kouvari MS, Alonistiotis D, Theodossiadis P. Long-term anatomical and functional results in patients undergoing observation for idiopathic nontractional epiretinal membrane. Eur J Ophthalmol. 2016 May-Jun;26(3):273-8.
  133. Aissopou EK, Argyris AA, Nasothimiou EG, Konstantonis GD, Tampakis K, Tentolouris N, Papathanassiou M, Theodossiadis PG, Papaioannou TG, Stehouwer CD, Sfikakis PP, Protogerou AD. Ambulatory Aortic Stiffness Is Associated With Narrow Retinal Arteriolar Caliber in Hypertensives: The SAFAR Study. Am J Hypertens. 2016 May;29(5):626-33.
  134. Chatziralli I, Theodossiadis G, Parikakis E, Datseris I, Theodossiadis P. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study. Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):223-33.
  135. Papaioannou L, Miligkos M, Papathanassiou M. Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis. Cornea. 2016 Jan;35(1):62-71.
  136. Aissopou EK, Papathanassiou M, Nasothimiou EG, Konstantonis GD, Tentolouris N, Theodossiadis PG, Papaioannou TG, Sfikakis PP, Protogerou AD. The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years. J Hypertens. 2015 Nov;33(11):2303-9.
  137. Chatziralli I, Theodossiadis G, Emfietzoglou I, Theodossiadis P. Intravitreal ranibizumab for choroidal neovascularization secondary to gyrate atrophy in a young patient: a multimodal imaging analysis. Eur J Ophthalmol. 2015 Oct 21;25(6):e119-22.
  138. Theodossiadis GP, Chatziralli IP, Sergentanis TN, Datseris I, Theodossiadis PG. Evolution of vitreomacular adhesion to acute vitreofoveal separation with special emphasis on a traction-induced foveal pathology. A prospective study of spectral-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2015 Sep;253(9):1425-35.
  139. Theodossiadis GP, Chatziralli IP, Theodossiadis PG. Macular buckling in optic disc pit maculopathy in association with the origin of macular elevation: 13-year mean postoperative results. Eur J Ophthalmol. 2015 May-Jun;25(3):241-8.
  140. Rouvas A, Nikita E, Chatziralli I, Ladas I, Androu A, Theodossiadis P. Long- term follow-up of standard photodynamic therapy with standardized small spot size for diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 2015 May- Jun;25(3):229-34.
  141. Yfantopoulos J, Rouvas A, Chatzaras A, Xanthopoulou P, Theodosiadis P. Outcomes of Patients With Neovascular Age-Related Macular Degeneration (Namd) In Greece Under Ranibizumab. Value Health. 2014 Nov;17(7):A604.
  142. Douvali M, Chatziralli IP, Theodossiadis PG, Chatzistefanou KI, Giannakaki E, Rouvas AA. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema. Ophthalmologica. 2014;232(3):136-43.
  143. Theodossiadis PG, Eleftheriadou MI, Emfietzoglou I, Grigoropoulos V, Papathanassiou M, Theodossiadis GP. Evolution of full-thickness macular hole formation in a case of myopic foveoschisis. Semin Ophthalmol. 2014 Jul;29(4):210-2.
  144. 144. Rouvas AA, Chatziralli IP, Ladas ID, Xanthopoulou V, Giannakaki E, Karamboula A, Galanis D, Datseris I, Alonistiotis D, Diamanti R, Tsilimbaris M, Chalkia A, Theodossiadis P. The impact of financial crisis on central serous chorioretinopathy in Greece: is there any correlation? Eur J Ophthalmol. 2014 Jul-Aug;24(4):559-65.
  145. Theodoropoulou S, Samoli E, Theodossiadis PG, Papathanassiou M, Lagiou A, Lagiou P, Tzonou A. Diet and cataract: a case-control study. Int Ophthalmol. 2014 Feb;34(1):59-68.
  146. Petrou P, Georgalas I, Markomichelakis N, Vergados I, Gianakaki E, Rouvas A. Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization. Ther Clin Risk Manag. 2013;9:391-4.
  147. Rouvas A, Malamos P, Douvali M, Ntouraki A, Markomichelakis NN. Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia. Clin Ophthalmol. 2013;7:1357-62.
  148. Milia M, Lefatzis N, Papakosta V, Theodossiadis P, Papathanassiou M. Unusual case of orbital apex syndrome after chalazion excision. Clin Exp Optom. 2013 May;96(3):346-8.
  149. Papathanassiou M, Theodoropoulou S, Analitis A, Tzonou A, Theodossiadis PG. Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis. Cornea. 2013 Apr;32(4):435-44.
  150. Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P, Gialeraki A. Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis. 2013 Apr;24(3):279-83.
  151. Rouvas A, Nikita E, Markomichelakis N, Theodossiadis P, Pharmakakis N. Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis: clinical course and treatment. J Ophthalmic Inflamm Infect. 2013 Jan 25;3(1):21.
  152. Eleftheriadou M, Theodossiadis P, Rouvas A, Alonistiotis D, Theodossiadis G. New optical coherence tomography fundus findings in a case of beta-thalassemia. Clin Ophthalmol. 2012;6:2119-22.
  153. Ladas ID, Chatziralli IP, Kotsolis AI, Douvali M, Georgalas I, Theodossiadis PG, Rouvas AA. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration. Ophthalmologica. 2012;228(2):93-101.
  154. Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina. 2012 Jun;32(6):1181-9.
  155. Theodossiadis GP, Grigoropoulos VG, Liarakos VS, Rouvas A, Emfietzoglou I, Theodossiadis PG. Restoration of the photoreceptor layer and improvement of visual acuity in successfully treated optic disc pit maculopathy: a long follow- up study by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012 Jul;250(7):971-9.
  156. Rouvas A, Stavrakas P, Theodossiadis PG, Stamatiou P, Milia M, Giannakaki E, Datseris I. Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy. Eur J Ophthalmol. 2012 May-Jun;22(3):417-22.
  157. Papathanassiou M, Zampeli E, Mehta JS, Theodossiadis P. Unusual case of silent corneal perforation in a human immunodeficiency virus-infected patient. Clin Exp Optom. 2011 Nov;94(6):589-91.
  158. Papathanassiou M, Petrou P, Rallidis M, Theodossiadis P. Presumed sterile corneal ulcer following autologous limbal stem cell and amniotic membrane transplantation: report of an unusual complication. Clin Exp Optom. 2011 Sep;94(5):484-7.
  159. Rouvas A, Petrou P, Vergados I, Theodossiadis G, Theodossiadis P. Extensive submacular hemorrhage following intravitreal ranibizumab for small occult choroidal neovascular membrane. Eur J Ophthalmol. 2011 Sep-Oct;21(5):665-7.
  160. Rouvas AA, Ladas ID, Georgalas I, Vergados I, Papakonstantinou D, Kotsolis AI. Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear. Retina. 2011 Jun;31(6):1083-8.
  161. Kalogeromitros DC, Makris MP, Aggelides XS, Mellios AI, Giannoula FC, Sideri KA, Rouvas AA, Theodossiadis PG. Allergy skin testing in predicting adverse reactions to fluorescein: a prospective clinical study. Acta Ophthalmol. 2011 Aug;89(5):480-3.
  162. Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Retina. 2011 May;31(5):871-9.
  163. Rouvas A, Petrou P, Ladas I, Vergados I, Andipa ES, Papathanasiou M, Markomichelakis N. Extensive unilateral visual field loss due to peripapillary arteriovenous malformation. Int Ophthalmol. 2011 Apr;31(2):135-9.
  164. Papathanassiou M, Giannoulaki V, Zampeli E, Tiligada E. Effect of aminoguanidine on the conjunctival histamine and nitrite levels in experimental conjunctivitis. J Ocul Pharmacol Ther. 2011 Apr;27(2):137-42.
  165. Rouvas AA, Papakostas TD, Ntouraki A, Douvali M, Vergados I, Ladas ID. Photodynamic therapy, ranibizumab, and ranibizumab with photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Retina. 2011 Mar;31(3):464-74.
  166. Papathanassiou M, Alonistiotis D, Petrou P, Theodossiadis P, Vergados I. Macular hole formation following phacoemulsification cataract surgery. Clin Exp Optom. 2011 Jan;94(1):112-4.
  167. Papathanassiou M, Petrou P, Papalexis G, Theodossiadis P. Intraoperative complication during phacoemulsification in patient with epidermolysis bullosa. J Cataract Refract Surg. 2011 Jan;37(1):198-200.
  168. Emfietzoglou I, Grigoropoulos V, Nikolaidis P, Theodossiadis G, Rouvas A, Theodossiadis P. Optical coherence tomography findings in a case of cone-rod dystrophy. Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-3.
  169. Rouvas AA, Papakostas TD, Ntouraki A, Douvali M, Vergados I, Ladas ID. Angiographic and OCT features of retinal angiomatous proliferation. Eye (Lond). 2010 Nov;24(11):1633-42; quiz 1643.
  170. Theodossiadis P, Charonis A, Panagiotidis D, Papathanassiou M, Petrou P. Vitrectomy for treatment of a lamellar hole in a patient with exudative macular degeneration: the role of vitreous traction elimination. Eur J Ophthalmol. 2010 Nov-Dec;20(6):1086-8.
  171. Papathanassiou M, Zampeli E, Kaplanoglou T, Theodossiadis P. Peripheral ulcerative keratitis in a patient with systemic-onset juvenile idiopathic arthritis. J Pediatr Ophthalmol Strabismus. 2010 Oct 21;47 Online:e1-3.
  172. Ladas ID, Kotsolis AI, Ladas DS, Niskopoulou M, Georgalas I, Papakonstantinou D, Rouvas AA. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Retina. 2010 Sep;30(8):1185-9.
  173. Papathanassiou M, Nikita E, Theodossiadis P, Vergados I. Orbital metastasis secondary to breast cancer mimicking thyroid-associated ophthalmopathy. Clin Exp Optom. 2010 Sep;93(5):368-9.
  174. Papathanassiou M, Nikita E, Theodossiadis P, Theodossiadis GP, Vergados I. Exemestane-induced corneal epithelial changes. Cutan Ocul Toxicol. 2010 Sep;29(3):209-11.
  175. Papathanassiou M, Elezoglu A, Nikita E, Theodossiadis PG, Vergados I. A rare case of peripheral ulcerative keratitis in temporal arteritis. Eur J Ophthalmol. 2009 Sep-Oct;19(5):866-9.
  176. Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study. Retina. 2010 Jun;30(6):893-902.
  177. Georgalas I, Rouvas A, Kotsolis A, Karagiannis D, Ladas I. Full Thickness Macular Hole Formation in a Patient with Cystoid Macular Edema Caused by CRVO Treated with Intravitreal Bevacizicumab. Ophthalmic Surg Lasers Imaging. 2010 Mar 9:1-4.
  178. Emfietzoglou I, Grigoropoulos V, Nikolaidis P, Theodossiadis G, Rouvas A, Theodossiadis P. Optical coherence tomography findings in a case of cone-rod dystrophy. Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-3.
  179. Rouvas AA, Papakostas TD, Ladas ID. Ranibizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1719-20.
  180. Rouvas A, Petrou P, Vergados I, Pechtasides D, Liarakos V, Mitsopoulou M, Ladas I. Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1609-16.
  181. Rouvas A, Petrou P, Maselos S, Douvali M, Vergados I, Markomichelakis N. Retinal angiomatous proliferation (RAP) in a 42-year-old woman with syphilitic retinitis. Ocul Immunol Inflamm. 2009 Sep-Oct;17(5):361-3.
  182. Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I, Vergados I. The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica. 2009;223(6):383-9.
  183. Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, Ladas ID. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina. 2009 Apr;29(4):536-44.
  184. Ladas ID, Karagiannis DA, Rouvas AA, Kotsolis AI, Liotsou A, Vergados I. Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections. Retina. 2009 Mar;29(3):313-8.
  185. Rouvas A, Liarakos VS, Theodossiadis P, Papathanassiou M, Petrou P, Ladas I, Vergados I. The effect of intravitreal ranibizumab on the fellow untreated eye with subfoveal scarring due to exudative age-related macular degeneration. Ophthalmologica. 2009;223(6):383-9.
  186. Georgalas I, Rouvas AA, Karagiannis DA, Kotsolis AI, Ladas ID. Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex. Clin Ophthalmol. 2009;3:13-6.
  187. Tzepi I, Vergados I, Kanellakopoulou K, Papathanassiou M, Kranidioti H, Tsaganos T, Liarakos V, Giamarellos-Bourboulis EJ, Theodossiadis P. Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study. Int J Antimicrob Agents. 2009 Feb;33(2):160-2.
  188. Papathanassiou M, Liarakos VS, Vaikousis E, Paschalidis T, Agrogiannis G, Vergados I. Corneal melt in lattice corneal dystrophy type II after cataract surgery. J Cataract Refract Surg. 2009 Jan;35(1):185-9.
  189. Papathanassiou M, Petrou P, Zampeli E, Vergados I, Paikos P. Disseminated hydatid disease in a child: albendazole treatment of orbital cyst. Eur J Ophthalmol. 2008 Nov-Dec;18(6):1034-6.
  190. Papathanassiou M, Theodossiadis PG, Liarakos VS, Rouvas A, Giamarellos- Bourboulis EJ, Vergados IA. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model. Am J Ophthalmol. 2008 Mar;145(3):424-431.
  191. Rouvas AA, Papakostas TD, Ladas ID, Vergados I. Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):315-8.
  192. Rouvas A, Petrou P, Ladas I, Neamonitou G, Vergados I. Spontaneous resolution of vitreomacular traction following ranibizumab (Lucentis) injection. Eur J Ophthalmol. 2008 Mar-Apr;18(2):301-3.
  193. Rouvas AA, Ladas ID, Papakostas TD, Moschos MM, Vergados I. Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to multiple evanescent white dot syndrome. Eur J Ophthalmol. 2007 Nov-Dec;17(6):996-9.
  194. Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Retina. 2007 Sep;27(7):891-6.
  195. Kalogeromitros DC, Makris MP, Rouvas A, Theodossiadis PG, Spanoudaki N, Papaioannou D. Skin testing and adverse reactions in fluorescein: a prospective study. Allergy Asthma Proc. 2007 Jul-Aug;28(4):472-6.
  196. Theodossiadis P, Rouvas A, Nakopoulou L, Halvatziotis P, Magkou C, Vergados I. Epithelioid trophoblastic tumor. Ophthalmology. 2007 Jul;114(7):1421.